HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway.

Abstract
Alzheimer's disease (AD) is the most prevalent type of dementia in elderly people. There are decreased melatonin levels in the serum of AD patients, and melatonin supplements are able to reverse AD pathology and memory deficits in many animal experiments and clinical trials. However, the underlying mechanism regarding how melatonin rescues the AD-like memory/synaptic disorder remains unknown. Here, we use the Morris water maze, step-down inhibitory avoidance task, in vivo long-term potentiation recording, and Golgi staining and report that intraperitoneal injection of melatonin (1 mg/kg/day) for 14 days in rats effectively reverses the memory and synaptic impairment in scopolamine-induced amnesia, a well-recognized dementia animal model. Using real-time polymerase chain reaction and western blotting experiments, we further determined that melatonin rescues the EPACs/miR-124/Egr1 signal pathway, which is important in learning and memory, as reported recently. Our studies provide a novel underlying epigenetic mechanism for melatonin to attenuate the synaptic disorder and could benefit drug discovery in neurodegenerative diseases.
AuthorsXiong Wang, Zhi-Hao Wang, Yuan-Yuan Wu, Hui Tang, Lu Tan, Xiang Wang, Xin-Ya Gao, Yan-Si Xiong, Dan Liu, Jian-Zhi Wang, Ling-Qiang Zhu
JournalMolecular neurobiology (Mol Neurobiol) Vol. 47 Issue 1 Pg. 373-81 (Feb 2013) ISSN: 1559-1182 [Electronic] United States
PMID23054680 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Early Growth Response Protein 1
  • Egr1 protein, rat
  • Guanine Nucleotide Exchange Factors
  • MIRN124 microRNA, rat
  • MicroRNAs
  • Rapgef3 protein, rat
  • Scopolamine
  • Melatonin
Topics
  • Animals
  • Early Growth Response Protein 1 (metabolism)
  • Guanine Nucleotide Exchange Factors (metabolism)
  • Male
  • Melatonin (pharmacology, therapeutic use)
  • Memory Disorders (drug therapy, physiopathology)
  • MicroRNAs (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Scopolamine
  • Signal Transduction (drug effects)
  • Synapses (drug effects, pathology)
  • Synaptic Transmission (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: